Manufacturing and Production

Showing 15 posts of 5866 posts found.

howard_schiller_valeant

Valeant likely to restate financial results after Philidore review

February 23, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Howard Schiller, Philidore, Valeant

Valeant says it is likely to restate its financial results for the last two years, in the wake of the …
viiv_healthcare

ViiV completes BMS HIV pipeline purchase

February 23, 2016 Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, GSK, HIV, Pfizer, Shionogi, ViiV

ViiV Healthcare has completed its previously-announced acquisition of Bristol-Myers Squibb’s late-stage HIV R&D assets and its portfolio of preclinical and …
fda

Califf clears key hurdle to FDA top job

February 23, 2016 Manufacturing and Production, Medical Communications, Research and Development

Dr Robert Califf, President Obama’s nominee to head up the US Food and Drugs Administration as commissioner, has edged a …

Europe approves Bayer haemophilia drug

February 22, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, haemophilia a

Bayer has received approval from the European Commission for its haemophilia A drug Kovaltry (octocog alfa) in patients of all …
pharmafocus_march_front_cover

March edition of Pharmafocus live

February 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The March 2016 edition of Pharmafocus is now live and available to read here.
malcolm_farnan

MPS appoints global marketing leader

February 17, 2016 Manufacturing and Production

Multi Packaging Solutions International, a global leader in value-added print and packaging solutions for the branded consumer, healthcare and multi-media …
image_via_the_dementia_consortium

AbbVie becomes Dementia Consortium’s latest pharma partner

February 16, 2016 Manufacturing and Production, Research and Development

AbbVie has become the latest pharmaceutical company to join The Dementia Consortium- a £4 million global collaboration aiming to speed …
brexit

What would BREXIT mean for pharma?

February 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development

It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
samsung_bioepis

First Enbrel biosimilar launches in UK

February 16, 2016 Manufacturing and Production, Research and Development Enbrel, Samsung Bioepis, eternacept, rheumatoid arthritis

Following its approval by the European Commission in January, Benepali has become the first biosimilar of Pfizer/Amgen’s Enbrel (etanercept) to …
eli_lilly

Lilly suffers damaging Alimta patent blow

February 15, 2016 Manufacturing and Production, Sales and Marketing Actavis, Alimta, Allergan, Eli Lilly, pemetrexed

Eli Lilly says it plans to appeal a UK High Court’s verdict that could imminently open its blockbuster lung cancer …
cancer_cells_blue

New 10-minute test will diagnose cancer at home

February 15, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Cancer

Scientists have developed a test for cancer that can diagnose the disease at home with the aid of just a …
albert_bourla

Pfizer names leadership team post-Allergan merger

February 9, 2016 Manufacturing and Production, Sales and Marketing Allergan, Pfizer

Pfizer has announced the executive leadership team for the combined Pfizer and Allergan business once the $160 billiion merger deal …
aedes_aegypti_mosquito

INTERVIEW: Tackling the Zika threat

February 9, 2016 Manufacturing and Production, Medical Communications Zika, vaccines

The Zika outbreak which started in Brazil and spread rapidly to other south American countries and beyond has taken the …
fda

FDA set to approve Remicade biosimilar

February 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Remicade, biosimilars, remsima

An FDA committee has had some positive words for Celltrion’s biosimilar candidate to Janssen/MSD’s Remicade (infliximab), concluding that the copycat biologic …

NICE changes mind on Amgen’s cholesterol drug

February 8, 2016 Manufacturing and Production, Sales and Marketing Amgen, NICE, Repatha

NICE has changed its mind on Amgen’s cholesterol-busting drug Repatha (evolocumab), and decided to recommend approval of the treatment in …
The Gateway to Local Adoption Series

Latest content